Evolent Health, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.9 | $2.6 | $2.0 | $1.4 | $0.9 |
| Operating income | -$0.4 | -$<0.1 | -$0.1 | $<0.1 | -$<0.1 |
| Net income | -$0.5 | -$0.1 | -$0.1 | -$<0.1 | -$<0.1 |
| Cash Flow Statement | |||||
| Free cash flow | — | — | $0.1 | -$<0.1 | $<0.1 |
| Share repurchases | $<0.1 | $0.0 | $0.0 | — | — |
Shares outstanding 112.5M · Free float 81.9%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.